Oxaliplatin Hospira 5 mg/ml concentrate for solution for infusion
Sponsors
Vastra Gotalandsregionen, Astellas Pharma Global Development Inc., Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA, Clinica Universidad De Navarra
Conditions
Advanced cancer of the stomach or the gastroesophageal junctionAdvanced pancreatic cancerLocalised Colon Cancer (stage II-III)Locally advanced colon cancer (LACC)
Phase 2
A Phase 2 Study of Zolbetuximab (IMAB362) as Monotherapy and in Combination with Chemotherapy and/or Immunotherapy in Subjects with Metastatic or Locally Advanced Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma and Locoregional Gastric or GEJ Adenocarcinoma Whose Tumors are Claudin (CLDN) 18.2 Positive.
Active, not recruitingCTIS2024-511649-21-00
Start: 2018-08-01Target: 48Updated: 2026-01-23
Phase II randomized trial to assess the effect of intensive vs standard adjuvant chemotherapy in localised colon cancer with circulating tumor DNA
Not yet recruitingCTIS2024-518131-11-02
Target: 124Updated: 2025-01-24
ANALYSIS OF EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED COLON CANCER.
Not yet recruitingCTIS2024-519825-39-00
Target: 238Updated: 2025-01-30